"10.1371_journal.pone.0033449","plos one","2012-03-13T00:00:00Z","Arne Christians; Christian Hartmann; Axel Benner; Jochen Meyer; Andreas von Deimling; Michael Weller; Wolfgang Wick; Markus Weiler","Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Clinical Cooperation Unit Neurooncology, German Cancer Research Center (DKFZ), Heidelberg, Germany; Division of Biostatistics, German Cancer Research Center (DKFZ), Heidelberg, Germany; Department of Neuropathology, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany; Department of Neurooncology at the National Center for Tumour Diseases, Heidelberg University Hospital, Heidelberg, Germany; Department of Neurology, University Hospital Zurich, Zurich, Switzerland; Department of General Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany; Department of Neuropathology, Institute of Pathology, Hannover Medical School (MHH), Hannover, Germany","Conceived and designed the experiments: AC CH AvD M. Weiler. Performed the experiments: AC JM. Analyzed the data: AC CH AB M. Weiler. Contributed reagents/materials/analysis tools: AVD M. Weiler WW. Wrote the paper: AC CH AB AvD M. Weller WW M. Weiler.","M. Weller has been a consultant to, and has received honoraria from MSD (former Schering-Plough, one company which manufactures temozolomide) and Oncomethylome Sciences. W. Wick has been a consultant to, and has received honoraria from MSD, Roche and Eli Lilly. All other authors have declared no conflicts of interest. This does not alter the authors adherence to all the PLoS ONE policies on sharing data and materials.","2012","03","Arne Christians","AC",8,TRUE,NA,NA,NA,NA,NA,NA,NA,NA,NA
